Streetbeat News

Products Services

GXAI

Gaxos.ai Inc. (NASDAQ:GXAI) shares surged after announcing the acquisition of rights to use AI-enabled biohacking technology from Ultiself, aiming to enhance its Gaxos Health product offering with improved customization and user experience.

Portfolio Pulse from Erica Kollmann

March 13, 2024 | 3:10 pm

SOS

SOS Ltd – ADR (NASDAQ:SOS) shares plummeted 30% to $1.49 after announcing a public offering of $7.85 million in ADSs and warrants. The offering includes 5,233,332 ADSs and warrants for an additional 10,466,664 ADSs at $1.50 each, exercisable immediately with a five-year term. The proceeds are aimed at funding cloud cryptocurrency mining, security, insurance, and general corporate purposes, with Maxim Group LLC as the placement agent. The offering is expected to close by March 15.

Portfolio Pulse from Henry Khederian

March 13, 2024 | 3:05 pm

EXPE

Expedia Group is expanding its global travel ecosystem through new and expanded partnerships, leveraging its technology and supply to offer unparalleled travel options and competitive pricing. This initiative aims to unlock growth for partners and provide unique experiences for travelers.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 2:58 pm

CCL

NCLH

RCL

Goldman Sachs has issued Buy ratings for Royal Caribbean (RCL) and Carnival Corp. (CCL), and a Neutral rating for Norwegian Cruise Lines (NCLH), citing industry shifts leading to improved business models and multi-year pricing tailwinds. Key factors include favorable supply/demand, new ship launches, advancements in revenue management, and land investments. RCL is noted for its leadership and upcoming launches like Icon of the Seas, expected to generate significant ticket price premiums.

Portfolio Pulse from Piero Cingari

March 13, 2024 | 2:48 pm

AMD

DARP

NACP

NVDA

AMD's AI ambitions are questioned as its stock surges, with concerns about its valuation and slower growth compared to Nvidia, which remains the preferred choice for AI applications. Despite AMD's stock rising 116% since late October, Wall Street projects slower growth and declining earnings estimates for AMD, while Nvidia's revenue is expected to jump 80% this fiscal year. Nvidia is seen as the leading near-term winner in AI, with its chips being the preferred choice and its stock trading at a more modest multiple compared to AMD. Investors can gain exposure to Nvidia through ETFs like NACP and DARP.

Portfolio Pulse from Anusuya Lahiri

March 13, 2024 | 2:37 pm

LLY

NVO

The pharmaceutical industry is facing a 50% increase in crime due to a surge in counterfeit weight-loss drugs, notably Novo Nordisk's Ozempic and Wegovy, and Eli Lilly's products. Criminals are exploiting supply shortages and high demand, fueled by social media and Hollywood. Both companies are taking significant steps to combat this issue, with Novo Nordisk working with authorities and employing third-party monitors, and Eli Lilly taking legal action against entities selling fraudulent products.

Portfolio Pulse from Vandana Singh

March 13, 2024 | 2:31 pm

TSLA

Elon Musk announced on X that the Tesla Giga Berlin factory is back online, thanking the Tesla team and community support.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 2:23 pm

IBIT

Bitcoin reached a new peak of $73,709, marking its fourth high in six days, driven by a surge in investments into U.S.-based Bitcoin ETFs, with a record $1.05 billion inflow on March 12. Blackrock's IBIT captured $849 million of this. Ether also rose 3.3% to $4,083, up 75% since the year's start. The Ethereum ecosystem anticipates cost reductions from the Dencun software update, benefiting Layer-2 networks like Arbitrum, Polygon, and Coinbase's Base.

Portfolio Pulse from Murtuza Merchant

March 13, 2024 | 2:23 pm

AZN

MNKTQ

SLN

Silence Therapeutics Plc (NASDAQ:SLN) reported a narrower loss per share for 2023 compared to the previous year and an increase in collaboration revenues. Despite this, shares dropped 5.61% to $24.45. The company announced significant cash position improvements and the conclusion of a collaboration with Mallinckrodt (OTC:MNKTQ) on SLN501. Positive data from the ALPACAR-360 phase 2 study of zerlasiran was also shared. Additionally, a $10 million milestone payment was triggered by AstraZeneca PLC (NASDAQ:AZN) for initiating a phase 1 clinical trial.

Portfolio Pulse from Nabaparna Bhattacharya

March 13, 2024 | 2:16 pm

IDAI

Trust Stamp (NASDAQ:IDAI) announced the commercial release of its new AI-powered age-estimation technology, designed to estimate the age of online users to ensure age-appropriate content access. The technology, which uses deep-learning algorithms, has been tested against industry leaders and is now in negotiations for its first commercial implementation. Trust Stamp's President, Andrew Gowasack, highlighted the technology's potential applications both online and offline, emphasizing its importance in complying with legislative initiatives on age verification.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 2:04 pm